| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 05/12/2005 | CA2541856A1 Modified polypeptides with therapeutic activity and methods of use |
| 05/12/2005 | CA2538695A1 Clq related protein |
| 05/12/2005 | CA2537236A1 Anti-angiogenic peptides for treating or preventing endometriosis |
| 05/12/2005 | CA2534236A1 Lipoparticles comprising proteins, methods of making, and using the same |
| 05/12/2005 | CA2528370A1 Capture and release based isotope tagged peptides and methods for using the same |
| 05/11/2005 | EP1529845A2 Fusion glycoprotein from HCMV and HSV |
| 05/11/2005 | EP1529843A2 Novel secreted proteins and their uses |
| 05/11/2005 | EP1529842A2 Compositions and methods for the treatment of immune related diseases |
| 05/11/2005 | EP1529784A1 Polymeric anhydride of magnesium and proteic ammonium phospholinoleate-palmitoleate. |
| 05/11/2005 | EP1529535A1 Isolation of a circulating human lipolytic peptide |
| 05/11/2005 | EP1529118A1 Avian sex determination method |
| 05/11/2005 | EP1529114A1 Process for preparing peptides with anti-hypertensive properties |
| 05/11/2005 | EP1529113A1 Vaccinia virus host range genes to increase the titer of avipoxviruses |
| 05/11/2005 | EP1529108A2 Albumin-fused ciliary neurotrophic factor |
| 05/11/2005 | EP1529107A2 Dna vaccines against hantavirus infections |
| 05/11/2005 | EP1529105A1 Methods to reprogram splice site selection in pre-messenger rnas |
| 05/11/2005 | EP1529103A1 Method for inducing complete hepatitis c virus (hcv) replication in vitro |
| 05/11/2005 | EP1529064A2 Heteropolymeric compound comprising a scaffold, an adjuvant and an antigen, and its use |
| 05/11/2005 | EP1529062A2 Diagnostic and therapeutic use of kremen 1 and 2, inhibitors of the canonical wnt-signaltransduction |
| 05/11/2005 | EP1529061A1 Method for isolating an intestinal cholesterol binding protein |
| 05/11/2005 | EP1529060A2 Method for the production of an immunostimulating mucin (muc1) |
| 05/11/2005 | EP1529059A2 Porcine leptin protein, antisense and antibody |
| 05/11/2005 | EP1529058A2 A non-selective cation channel in neural cells and methods for treating brain swelling |
| 05/11/2005 | EP1529057A2 Biphalin derivatives and their analgesic applications |
| 05/11/2005 | EP1529056A2 Post-cleavage sulfur deprotection for convergent protein synthesis by chemical ligation |
| 05/11/2005 | EP1529055A2 Isolated nucleic acid molecule encoding a novel centromere-associated motor protein, and uses thereof |
| 05/11/2005 | EP1529054A2 Therapeutic protein and treatments |
| 05/11/2005 | EP1528932A2 Novel motor protein of p. falciparum and methods for its use |
| 05/11/2005 | EP1470114A4 Peptide nucleic acid oligomers from 1-benzenesulfonyl-3-amino acid side chain-4-(2-nucleobase(acetyl))-piperazin-2-ones |
| 05/11/2005 | EP1456397A4 52908, a human potassium channel, and uses thereof |
| 05/11/2005 | EP1412375A4 Alteration of oil traits in plants |
| 05/11/2005 | EP1409508A4 Mammalian neuralized family transcriptional regulators and uses therefor |
| 05/11/2005 | EP1390399B1 Long lasting fusion peptide inhibitors for hiv infection |
| 05/11/2005 | EP1366168A4 Plant-derived molecules and genetic sequences encoding same and uses therefor |
| 05/11/2005 | EP1286590A4 Peptide analogs and mimetics suitable for in vivo use in the treatment of diseases associated with abnormal protein folding into amyloid, amyloid-like deposits or beta-sheet rich pathological precursor thereof |
| 05/11/2005 | EP1259825B1 Method for carrying out the differential diagnostic determination of autoantibodies formed against the tsh receptor in a serum sample or plasma sample of a patient |
| 05/11/2005 | EP1250430B1 Regulatory sequence for the specific expression in dendritic cells and uses thereof |
| 05/11/2005 | EP1248802B9 Soluble ctla4 mutant molecules and uses thereof |
| 05/11/2005 | EP1231830A4 Compositions and methods for modulation of plant cell division |
| 05/11/2005 | EP1159620B1 Detection of mtoc disrupting substances |
| 05/11/2005 | EP1105738B1 Assays for modulating nuclear localisation |
| 05/11/2005 | EP1088069B1 Angiostatin-binding protein |
| 05/11/2005 | EP1036092B1 Hydrophobically-modified hedgehog protein compositions and methods |
| 05/11/2005 | EP0993470B1 Antibodies and other binding molecules specific for hepatitis b viral antigens |
| 05/11/2005 | EP0987943B1 Detecting and treating cancer |
| 05/11/2005 | EP0951464B1 N-(aryl/heteroarylacetyl) amino acid esters, pharmaceutical compositions comprising same, and methods for inhibiting beta-amyloid peptide release and/or its synthesis by use of such compounds |
| 05/11/2005 | EP0894094B1 Process for extraction of a growth factor complex |
| 05/11/2005 | EP0854915B1 Cd23 cleavage enzyme preparation |
| 05/11/2005 | EP0853124B1 Dna encoding porcine complement inhibitor |
| 05/11/2005 | EP0839196B1 Human ctla-8 and uses of ctla-8-related proteins |
| 05/11/2005 | EP0730606B1 Hu-B1.219, A NOVEL HUMAN HEMATOPOIETIN RECEPTOR |
| 05/11/2005 | EP0575350B1 Methods for the ex-vivo replication and stable genetic transformation of human stem cells |
| 05/11/2005 | EP0572478B1 Hbgad and higad polypeptides and nucleic acids and their use for the diagnosis and treatment of gad autoantigen associated diseases |
| 05/11/2005 | CN1615440A Composition comprising and method of using angiopoietin-like protein 3 ANGPTL3 |
| 05/11/2005 | CN1615439A Genes encoding g-protein coupled receptors and methods of use therefor |
| 05/11/2005 | CN1615368A Effectors of innate immunity |
| 05/11/2005 | CN1615364A HIV-1 virus tat-protein mutants |
| 05/11/2005 | CN1615362A Gene promoters |
| 05/11/2005 | CN1615361A Liver cancer deriving growth factor 5 of human, it coding sequence, preparation and use thereof |
| 05/11/2005 | CN1615360A Process for producing l-amino acid using escherichia |
| 05/11/2005 | CN1615359A Process for producing l-amino acid using escherichia |
| 05/11/2005 | CN1615316A Novel immunogenic mimetics of multimer proteins |
| 05/11/2005 | CN1615150A Assay for the detection of factors that modulate the expression of INGAP |
| 05/11/2005 | CN1614030A Gene artificial synthesis and SARS virus protective antigen-amino acid series |
| 05/11/2005 | CN1614022A Bt-cry1 Ah gene with high toxicity for lepidoptera and its expression product |
| 05/11/2005 | CN1614020A Drought tolerant use of pseudo-water chestnut zinc finger protein gene AtRINGF1 |
| 05/11/2005 | CN1614019A Secretory expression for human insulin gene in methyl alcohol yeast |
| 05/11/2005 | CN1613872A Interferon of IFN-beta-cn and its mutant |
| 05/11/2005 | CN1613871A Method for rapid purifying soluble protein of shell pearl layer |
| 05/11/2005 | CN1613870A Tetramer combined with SARS antigen peptide and its preparation and use |
| 05/11/2005 | CN1201150C Composite, chemical luminescent system and its applications |
| 05/11/2005 | CN1201012C Alteration of flowering time in plants |
| 05/11/2005 | CN1201011C Heterologous expression of neisserial proteins |
| 05/11/2005 | CN1201010C Mass production method of antimicrobial peptide and DNA construct and expression system thereof |
| 05/11/2005 | CN1201007C i(NACl)-plant gene encoding transcription factor involved in cotyledon and lateral root development |
| 05/11/2005 | CN1201006C High-affinity interleukin-4 muteins |
| 05/11/2005 | CN1201004C HER-2/neu fusion proteins |
| 05/11/2005 | CN1201003C Adipocyte-specific protein homologs |
| 05/11/2005 | CN1200950C Immuno-conjugated compound as protein or nucleic acid trasnferring carrier |
| 05/11/2005 | CN1200949C Covalently bridged insulin dimers |
| 05/11/2005 | CN1200948C Heparin chromatography of erythropoietins |
| 05/11/2005 | CN1200735C Model animal of mesangial cell proliferative nephritis |
| 05/11/2005 | CN1200731C Derivatives of pneumococcal choline binding proteins for vaccines |
| 05/10/2005 | US6892140 Immunogenic cancer peptides and uses thereof |
| 05/10/2005 | US6891088 For increased yield/oil/modified starch (amylose) content |
| 05/10/2005 | US6891085 Nucleotidesequences coding polypeptide associated with the generation of disease resistant plants |
| 05/10/2005 | US6891082 Transgenic nonhuman animal whose genome contains a nucleic acid sequence comprising a truncated Activin Type II receptor gene and a muscle-specific promoter operably linked and integrated into genome of animal; increased muscle mass |
| 05/10/2005 | US6891081 Transgenic mice over-expressing amyloid-beta alcohol dehydrogenase (ABAD) in brain as model of alzheimer's disease and uses thereof |
| 05/10/2005 | US6891031 Nucleotide sequences for use in controlling gene expression |
| 05/10/2005 | US6891030 T-cell immunoregulatory molecule |
| 05/10/2005 | US6891029 Isolated polynucleotide sequences encoding a fertility associated antigen |
| 05/10/2005 | US6891028 Nucleic acids encoding transferrin receptor-like proteins |
| 05/10/2005 | US6891025 Capable of being crystallized without complexing to a ligand; human growth hormone receptor (hGHR) |
| 05/10/2005 | US6891021 Regulated apoptosis |
| 05/10/2005 | US6890902 Cytotoxic modified lactoferrin peptides |
| 05/10/2005 | US6890899 A lipolytic or lipid mobilising factor (LMF) produced by the cachexia-inducing murine tumor MAC16; weight reduction or controlling obesity; administering a Zn-alpha 2-glycoprotein |
| 05/10/2005 | US6890897 In combination with an osteoinductive protein and a bone morphogenetic protein or a hedgehog protein to induce osteogenesis; biocompatible or biodegradable matrix |
| 05/10/2005 | US6890751 NRG-2 nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods |
| 05/10/2005 | US6890749 Reagents and methods useful for detecting diseases of the prostate |
| 05/10/2005 | US6890748 Production of lysosomal enzymes in plants by transient expression |